drugset / Press release
KORTUC Phase 1 study is commenced in the UK
2017-03-01 · Kortuc, Inc. · original kortuc.com ↗
A Phase 1 study for locally advanced/recurrent breast cancer to evaluate the safety and tolerability of KORTUC (a novel radiation sensitizer) was started in the Royal Marsden Hospital in the UK. Further information can be found below Phase 1 study
The release as fetched from its publisher. kortuc.com ↗